ROBERT J. SHALHOUB, M.D.; UMA RAJAN, M.B.B.S.; VO V. KIM, M.D.; EUGENE GOLDWASSER, Ph.D.; JOHN A. KARK, M.D.; LUCY D. ANTONIOU, M.D.
Erythrocytosis was seen in two men during maintenance hemodialysis therapy for end-stage renal disease secondary to apparent chronic glomerulonephritis. Nonrenal causes of erythrocytosis such as polycythemia vera, chronic hypoxemia, high-oxygen affinity hemoglobin, and hepatoma were excluded by appropriate clinical studies. A computed tomographic scan of the abdomen showed numerous renal cysts in each patient consistent with acquired cystic disease of end-stage kidneys. Peripheral serum erythropoietin levels were elevated as measured by sensitive radioimmunoassay. The findings suggest that the erythrocytosis is caused by an erythropoietic mechanism related to the diseased kidneys. A review of the literature failed to show previous reports of this clinical association.
SHALHOUB RJ, RAJAN U, KIM VV, GOLDWASSER E, KARK JA, ANTONIOU LD. Erythrocytosis in Patients on Long-term Hemodialysis. Ann Intern Med. ;97:686–690. doi: 10.7326/0003-4819-97-5-686
Download citation file:
Published: Ann Intern Med. 1982;97(5):686-690.
Hematology/Oncology, Nephrology, Red Cell Disorders, Renal Replacement Therapy.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use